Canopy Growth Corporation (CGC) closed the most recent trading day at $9.18, moving +0.77% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.7%. Elsewhere, the Dow gained 0.01%, while the tech-heavy Nasdaq added 1.1%.The company's stock has climbed by 4.71% in the past month, exceeding the Medical sector's gain of 3.27% and the S&P 500's gain of 4.03%.Market participants will be closely following the financial results of Canopy Growth Corporation in its upcoming release. Th ...

Canopy Growth Corporation (CGC) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...

In the latest market close, Canopy Growth Corporation (CGC) reached $10.85, with a -1.36% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.12%. At the same time, the Dow added 0.34%, and the tech-heavy Nasdaq lost 0.07%.Shares of the company witnessed a gain of 40.49% over the previous month, beating the performance of the Medical sector with its gain of 5.73% and the S&P 500's gain of 4.99%.The investment community will be paying close attention to th ...

On paper, stakeholders of cannabis operator Canopy Growth (NASDAQ:CGC) have plenty of reasons to smile. Anticipation of major marijuana policy shifts culminated in a recent announcement by President Joe Biden that the government will reclassify the controversial plant. However, questions still dog CGC stock ahead of Canopy’s first-quarter earnings report.One of the most significant developments regarding the legalization movement came Thursday when President Biden posted a video message regarding his admini ...

Fans of Canopy Growth (NASDAQ:CGC) stock have plenty to look forward to following a recent proposal to reschedule cannabis. This, of course, includes its upcoming first-quarter earnings report, due on May 30. The entire cannabis industry has been on cloud nine of late following the U.S. Department of Justice's (DOJ) historic proposal to move forward with the re-classification of cannabis. Indeed, on Thursday, May 16, the DOJ released a proposal to reclassify the green plant from a Schedule I drug to a Sched ...

Canopy Growth Corporation (CGC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this company have returned +40.5% over the past month versus the Zacks S&P 500 composite's +5% change. The Zacks Medical - Products industry, to which Canopy Growth belongs, has gained 3.5% over this period. Now the key question is: Where could the stock be headed in the near term? While m ...

Canopy Growth Corporation (CGC) shares ended the last trading session 11% higher at $11. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 52.7% gain over the past four weeks.The surge in Canopy Growth's shares can be attributed to the U.S. Government's proposal to reclassify marijuana from Schedule I (reserved for drugs with a high potential for abuse) to Schedule III (reserved for drugs with a moderate to low poten ...

SMITHS FALLS, ON, May 16, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis, will release its financial results for the fourth quarter and fiscal year 2024 ended March 31, 2024 before financial markets open on May 30, 2024.Following the release of its fourth quarter and fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and J ...

Key Canadian Cannabis Stocks to Watch in Mid-May 2024As we explore the bustling Canadian cannabis market, several marijuana stocks stand out this week, warranting a closer look. These companies, thriving amid a globally expanding industry, have shown resilience and innovation. Recent statistics reveal the global cannabis market could reach USD 197.74 billion by 2028, according to Grand View Research. This forecast underscores significant growth potential, driven by increasing legalization and medical usage. ...

Pot stocks can sometimes trade like meme stocks, and investors need to be careful, or they may incur significant losses.Cannabis stocks were surging last week on the news that the Drug Enforcement Administration (DEA) is going to reclassify marijuana. It will no longer be a Schedule I drug alongside heroin and LSD. Instead, it will be moved to Schedule III, where ketamine and certain anabolic steroids are grouped.Usually, when there's some positive news around marijuana reform, shares of Tilray Brands (TLRY ...